SONOMA PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/72ce4765-36b0-467e-968e-5349d7f3f1d4/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-2.5M | 2025-04-01 – 2026-03-31 | evidence 0001683168-26-004871 |
| FY 2024 | $-3.7M | 2024-04-01 – 2025-03-31 | evidence 0001683168-25-004546 |
| FY 2023 | $-4.7M | 2023-04-01 – 2024-03-31 | evidence 0001683168-24-004275 |
| FY 2022 | $-4.6M | 2022-04-01 – 2023-03-31 | evidence 0001683168-23-004323 |
| FY 2021 | $-5.9M | 2021-04-01 – 2022-03-31 | evidence 0001683168-22-004940 |
| FY 2020 | $-3.4M | 2020-04-01 – 2021-03-31 | evidence 0001683168-21-002977 |
| FY 2019 | $-7.4M | 2019-04-01 – 2020-03-31 | evidence 0001683168-21-002977 |
| FY 2018 | $-11.3M | 2018-04-01 – 2019-03-31 | evidence 0001683168-19-002069 |
| FY 2017 | $-14.2M | 2017-04-01 – 2018-03-31 | evidence 0001683168-18-001786 |
| FY 2016 | $-13.0M | 2016-04-01 – 2017-03-31 | evidence 0001683168-17-001670 |
| FY 2015 | $-14.7M | 2015-04-01 – 2016-03-31 | evidence 0001683168-17-001670 |
| FY 2014 | $-6.7M | 2014-04-01 – 2015-03-31 | evidence 0001019687-15-002432 |
| FY 2013 | $-6.1M | 2013-04-01 – 2014-03-31 | evidence 0001019687-14-002591 |
| FY 2012 | $-3.4M | 2012-04-01 – 2013-03-31 | evidence 0001019687-13-002453 |
| FY 2011 | $-6.5M | 2011-04-01 – 2012-03-31 | evidence 0001019687-12-002202 |
| FY 2010 | $-7.5M | 2010-04-01 – 2011-03-31 | evidence 0001019687-12-002202 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SONOMA PHARMACEUTICALS, INC. — all facts · Revenue · Net Income